Omnicell Investor Presentation Deck
Convertible senior notes, net
Cash and cash equivalents
Net debt
Net debt/Non-GAAP EBITDA
Long-term debt, current portion, net
Long-term debt, net
Total debt, net
Cash and cash equivalents
Net debt
Net debt/Non-GAAP EBITDA
(a)
© 2023 Omnicell, Inc.
(a)
$
$
$
$
Omnicell, Inc.
Reconciliation of GAAP to Non-GAAP
(Unaudited, in thousands, except per share data and percentage)
Quarter Ended
September 30, 2023
$
Year Ended December
31, 2017
568,887
(446,840)
122,047
0.9
15,208
194,917
210,125
(32,424)
177,701
1.9
(a)
Net Debt / EBITDA = (Total Debt - Cash and Cash Equivalents) / Trailing Twelve Months Non-GAAP EBITDA
Revolver availability
Cash and cash equivalents
Liquidity
Revolver availability
Cash and cash equivalents
Liquidity
Quarter Ended
September 30, 2023
500,000
446,840
946,840
$
$
Year Ended December
31, 2017
$
$
280,500
32,424
312,924
26View entire presentation